[
  {
    "ts": null,
    "headline": "Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen",
    "summary": "Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.",
    "url": "https://finnhub.io/api/news?id=3929ae45f983ab1cd54d515cc09101569784b682d5ba18d464da1e92851c880c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734366222,
      "headline": "Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen",
      "id": 132012924,
      "image": "https://media.zenfs.com/en/ibd.com/f0c9b86e1d3e55868d65f913087e5294",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.",
      "url": "https://finnhub.io/api/news?id=3929ae45f983ab1cd54d515cc09101569784b682d5ba18d464da1e92851c880c"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Inc. stock outperforms competitors despite losses on the day",
    "summary": "Amgen Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=5eb18062101ef09429811006c2a39bd3ad1d3ecf8191dae5a6130cd4dc64d7a4",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734367140,
      "headline": "Amgen Inc. stock outperforms competitors despite losses on the day",
      "id": 132066873,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=5eb18062101ef09429811006c2a39bd3ad1d3ecf8191dae5a6130cd4dc64d7a4"
    }
  },
  {
    "ts": null,
    "headline": "Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease",
    "summary": "Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.",
    "url": "https://finnhub.io/api/news?id=b44c288ffd0de00bd8662b6f08780ba8554f0cfeda86ed18abbc56faa09b2c20",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734359322,
      "headline": "Viridian Therapeutics Skyrockets After Besting Amgen In Thyroid Eye Disease",
      "id": 132011411,
      "image": "https://media.zenfs.com/en/ibd.com/f0c9b86e1d3e55868d65f913087e5294",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Viridian Therapeutics stock popped Monday after the company scored a win in thyroid eye disease, a condition that causes the eyes to swell.",
      "url": "https://finnhub.io/api/news?id=b44c288ffd0de00bd8662b6f08780ba8554f0cfeda86ed18abbc56faa09b2c20"
    }
  },
  {
    "ts": null,
    "headline": "Upstream Bio: Treating Respiratory Disorders With TSLP Targeting Differentiation",
    "summary": "Upstream Bio is leveraging TSLP targeting for respiratory disorders treatment, with IPO funds and upcoming Chronic Rhinosinusitis data. Click for more on UPB.",
    "url": "https://finnhub.io/api/news?id=be95c85788fca2450cc3208167c85d94bd0cdf5d53e8e875c80da72bf4ac7b5e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734354195,
      "headline": "Upstream Bio: Treating Respiratory Disorders With TSLP Targeting Differentiation",
      "id": 132013625,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2174475332/image_2174475332.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Upstream Bio is leveraging TSLP targeting for respiratory disorders treatment, with IPO funds and upcoming Chronic Rhinosinusitis data. Click for more on UPB.",
      "url": "https://finnhub.io/api/news?id=be95c85788fca2450cc3208167c85d94bd0cdf5d53e8e875c80da72bf4ac7b5e"
    }
  },
  {
    "ts": null,
    "headline": "Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?",
    "summary": "The weight-loss drugs battle has grabbed Wall Street's attention and stoked shares of Eli Lilly and Novo Nordisk. But others are coming.",
    "url": "https://finnhub.io/api/news?id=6cb607d103415376d9d07c90278dcd33f958e24cf9dd571a2bc12ffbc7065c56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734354059,
      "headline": "Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf?",
      "id": 132010903,
      "image": "",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The weight-loss drugs battle has grabbed Wall Street's attention and stoked shares of Eli Lilly and Novo Nordisk. But others are coming.",
      "url": "https://finnhub.io/api/news?id=6cb607d103415376d9d07c90278dcd33f958e24cf9dd571a2bc12ffbc7065c56"
    }
  }
]